InflaRx presents e-poster presentation of post hoc analysis of SHINE study
PremiumThe FlyInflaRx presents e-poster presentation of post hoc analysis of SHINE study
2M ago
InflaRx presents new preclinical findings for INF904
Premium
The Fly
InflaRx presents new preclinical findings for INF904
2M ago
InflaRx N.V. Reports Mid-Year Financial Results
Premium
Company Announcements
InflaRx N.V. Reports Mid-Year Financial Results
3M ago
InflaRx Unveils INF904’s Market Potential
PremiumCompany AnnouncementsInflaRx Unveils INF904’s Market Potential
5M ago
InflaRx’s Drug Shows Life-Saving Potential in COVID-19
Premium
Company Announcements
InflaRx’s Drug Shows Life-Saving Potential in COVID-19
6M ago
InflaRx shares additional data, new analysis of PANAMO Phase III trial
Premium
The Fly
InflaRx shares additional data, new analysis of PANAMO Phase III trial
6M ago
InflaRx Advances Anti-Inflammatory Therapeutics
PremiumCompany AnnouncementsInflaRx Advances Anti-Inflammatory Therapeutics
8M ago
InflaRx N.V. Targets Immuno-Dermatology Growth
Premium
Company Announcements
InflaRx N.V. Targets Immuno-Dermatology Growth
8M ago
InflaRx announces INF904 development plans
Premium
The Fly
InflaRx announces INF904 development plans
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100